Insider Transactions

What Transcode Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	2	2

Shares traded

	3 months	12 months
Acquired	249,019,938	249,019,938
Disposed	0	0
Net activity	+249,019,938	+249,019,938

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
DEFJ, Llc	10% owner	Aug 03	Derivative Conversion · C	+2,020,582	—	—	14,134,481
DEFJ, Llc	10% owner	Aug 03	Derivative Conversion · C	+11,813,859	—	—	12,113,899
Fitzgerald Thomas A	Chief Financial Officer	Sep 28	Open-market buy · P	+49,350	$0.51	+$25.2K	56,318
Dudley Robert Michael	Chief Executive Officer	Sep 28	Open-market buy · P	+98,000	$0.51	+$50K	180,262
Dudley Robert Michael	Chief Executive Officer	Jun 21	Open-market buy · P	+12,000	$2.65	+$31.8K	82,262
Dudley Robert Michael	Chief Executive Officer	Jun 20	Open-market buy · P	+6,607	$2.55	+$16.8K	70,262
Dudley Robert Michael	Chief Executive Officer	Jun 09	Open-market buy · P	+19,000	$2.76	+$52.4K	61,155
Dudley Robert Michael	Chief Executive Officer	Sep 14	Open-market buy · P	+20,000	$1.15	+$23K	893,114
Fitzgerald Thomas A	Chief Financial Officer	Jun 16	Open-market buy · P	+12,000	$1.27	+$15.2K	139,377
Dudley Robert Michael	Chief Executive Officer	May 31	Open-market buy · P	+2,000	$1.87	+$3.74K	873,114
Dudley Robert Michael	Chief Executive Officer	May 27	Open-market buy · P	+28,000	$1.84	+$51.6K	871,114

Page 1 of 1 · showing the 11 most recent Sign up free to view all 11 transactions and filter by insider →

Comments